Latest News Archive
Please select Category, Year, and then Month to display items
![]()
The University of the Free State (UFS) has an enrolment plan for 2007–2019 that was approved by the Department of Higher Education and Training (DHET). The university is compelled to adhere to these enrolment targets, as over-enrolment poses a risk to the academic integrity, financial sustainability, and student success of the university.
The UFS received 47 000 applications for admission in 2018, of which 17 000 applicants received final admission. All admission letters clearly stipulate that admission is subject to availability of space during registration. The enrolment target for new first-time entering students for 2018 is 8 000, therefore only 8 000 students can be registered across the university’s three campuses during this intake period.
The Executive Management of the UFS welcomes the fact that President Jacob Zuma’s announcement on 16 December 2017 about free education for the poor and working class has allowed many more students the opportunity to register. Several meetings between the Executive Management and the Student Representative Council (SRC) have taken place since the beginning of 2018 to discuss the implications of the President’s announcement. Engagement with the SRC regarding the registration process is also continuously taking place.
Online registration for all students opened on 8 January 2018. The UFS has put several measures in place to assist new first-time entering undergraduate students. Furthermore, students who have moved into residences and participated in the university’s Gateway Programme, as well as students who arrived on campus, were assisted to register for programmes with available space. In cases where the first option of study was full, students were redirected to other programmes with available space within the specific faculty or other faculties, provided that they comply with the relevant admission criteria. Only mainstream programmes in the Faculty of Economic and Management Sciences now have space left. The rest of the undergraduate programmes in all faculties on all the campuses are full.
Students who could not be accommodated in any of the programmes due to limited space are being directed to the Central Application Clearing House (CACH).
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology